Vicarious Surgical Inc (NYSE:RBOT) CEO Adam David Sachs Sells 943 Shares

Vicarious Surgical Inc (NYSE:RBOT) CEO Adam David Sachs sold 943 shares of the business’s stock in a transaction that occurred on Thursday, February 20th. The stock was sold at an average price of $14.53, for a total value of $13,701.79. Following the sale, the chief executive officer now directly owns 52,699 shares in the company, valued at $765,716.47. The trade was a 1.76 % decrease in their ownership of the stock. The sale was disclosed in a legal filing with the Securities & Exchange Commission, which can be accessed through the SEC website.

Adam David Sachs also recently made the following trade(s):

• On Monday, December 23rd, Adam David Sachs sold 139 shares of Vicarious Surgical stock. The stock was sold at an average price of $12.27, for a total value of $1,705.53.
• On Tuesday, December 3rd, Adam David Sachs sold 463 shares of Vicarious Surgical stock. The shares were sold at an average price of $13.50, for a total value of $6,250.50.

Vicarious Surgical Stock Performance

RBOT opened at $14.38 on Friday. The stock has a market cap of $84.96 million, a price-to-earnings ratio of -1.40 and a beta of 1.32. The stock’s 50 day moving average price is $13.65 and its 200-day moving average price is $10.08. Vicarious Surgical Inc has a one year low of $4.27 and a one year high of $19.00.

Institutional Inflows and Outflows

A number of hedge funds have recently modified their holdings of the business. Renaissance Technologies LLC lifted its holdings in Vicarious Surgical by 11.6% during the fourth quarter. Renaissance Technologies LLC now owns 11,534 shares of the company’s stock worth $152,000 after buying an additional 1,200 shares during the period. Geode Capital Management LLC lifted its holdings in shares of Vicarious Surgical by 8.2% during the 4th quarter. Geode Capital Management LLC now owns 30,799 shares of the company’s stock valued at $405,000 after purchasing an additional 2,336 shares during the last quarter. Finally, DnB Asset Management AS lifted its holdings in shares of Vicarious Surgical by 21.1% during the 4th quarter. DnB Asset Management AS now owns 21,213 shares of the company’s stock valued at $279,000 after purchasing an additional 3,692 shares during the last quarter. Institutional investors own 47.27% of the company’s stock.

Wall Street Analysts Forecast Growth

Separately, Piper Sandler cut their target price on Vicarious Surgical from $12.00 to $10.50 and set a “neutral” rating on the stock in a research note on Wednesday, November 13th.

Vicarious Surgical Company Profile

Vicarious Surgical Inc operates as a robotics technology company in the United States. The company focuses on developing and commercializing Vicarious System, a single-incision surgical robot that virtually transports surgeons inside the patient to perform minimally invasive surgery. Vicarious Surgical Inc was incorporated in 2014 and is headquartered in Waltham, Massachusetts.